Evidence map›Paper›PMID 36813533›Full record

ArticleRNA (New York, N.Y.)2023

Single-molecule RNA in situ detection in clinical FFPE tissue sections by vsmCISH.

Meng Jiang, Kaipeng Wei, Meiqing Li, Chen Lin, Rongqin Ke

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meng JiangSchool of Medicine, Huaqiao University, Quanzhou, Fujian, China.ORCID 0000-0003-1206-0468
Kaipeng WeiDepartment of Pathology, The 910 Hospital, Quanzhou, Fujian, China.
Meiqing LiDepartment of Pathology, Women and Children's Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Chen LinSchool of Medicine, Huaqiao University, Quanzhou, Fujian, China rke@hqu.edu.cn chen.lin@hqu.edu.cn.
Rongqin KeSchool of Medicine, Huaqiao University, Quanzhou, Fujian, China rke@hqu.edu.cn chen.lin@hqu.edu.cn.ORCID 0000-0002-9868-3713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although RNA plays a vital role in gene expression, it is less used as an in situ biomarker for clinical diagnostics than DNA and protein. This is mainly due to technical challenges caused by the low expression level and easy degradation of RNA molecules. To tackle this issue, methods that are sensitive and specific are needed. Here, we present an RNA single-molecule chromogenic in situ hybridization assay based on DNA probe proximity ligation and rolling circle amplification. When the DNA probes hybridize into close proximity to the RNA molecules, they form a V-shape structure and mediate the circularization of circle probes. Thus, our method was termed vsmCISH. We successfully applied our method to assess

Indexed as

DNARNADNA ProbesIn Situ HybridizationRNA, MessengerDNADNA ProbesRNARNA, MessengerRNA in situ hybridizationrolling circle amplificationsingle-molecule detection

Identifiers

PMID36813533
PMCPMC10187679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.